GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » Net Margin %

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Net Margin % : 20.76% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Sun Pharmaceuticals Industries's Net Income for the three months ended in Dec. 2023 was ₹25,238 Mil. Sun Pharmaceuticals Industries's Revenue for the three months ended in Dec. 2023 was ₹121,569 Mil. Therefore, Sun Pharmaceuticals Industries's net margin for the quarter that ended in Dec. 2023 was 20.76%.

The historical rank and industry rank for Sun Pharmaceuticals Industries's Net Margin % or its related term are showing as below:

NSE:SUNPHARMA' s Net Margin % Range Over the Past 10 Years
Min: 8.04   Med: 14.09   Max: 23.22
Current: 19.08


NSE:SUNPHARMA's Net Margin % is ranked better than
87.44% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.37 vs NSE:SUNPHARMA: 19.08

Sun Pharmaceuticals Industries Net Margin % Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Net Margin % Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.29 11.65 8.74 8.52 19.58

Sun Pharmaceuticals Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.51 18.50 17.16 19.79 20.76

Competitive Comparison of Sun Pharmaceuticals Industries's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharmaceuticals Industries's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Net Margin % falls into.



Sun Pharmaceuticals Industries Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sun Pharmaceuticals Industries's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=84735.8/432788.7
=19.58 %

Sun Pharmaceuticals Industries's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=25237.5/121568.6
=20.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sun Pharmaceuticals Industries  (NSE:SUNPHARMA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sun Pharmaceuticals Industries Net Margin % Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description

Traded in Other Exchanges
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines

No Headlines